Form 4: Exact Sciences EVP Sarah Condella Reports Stock Transactions

Sarah Condella, EVP of Human Resources at Exact Sciences, reports the vesting of restricted stock units, subsequent sale of shares to cover taxes, and new grants of restricted stock units.

Summary

• On February 26, 2024, Sarah Condella vested 3,954 shares of common stock from restricted stock units.
• Also on February 26, 2024, Condella was granted 15,834 restricted stock units.
• On February 27, 2024, Condella sold 1,880 shares at $56.89 per share to cover withholding taxes related to the vesting of restricted stock units.
• Following these transactions, Condella directly owns 73,732 shares of common stock and indirectly owns 5,726 shares held in a 401(k) plan.
• Condella also holds 93,029 vested and unvested options and restricted stock units.
• The newly granted restricted stock units will vest in four equal annual installments beginning on February 28, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and expected as part of executive compensation. There is no indication of unusual activity or concern.

Positives

• The vesting of restricted stock units indicates confidence in the company's future performance.
• The grant of additional restricted stock units to Condella aligns her interests with those of the shareholders.

Negatives

• The sale of shares to cover taxes, while routine, slightly reduces Condella's direct holdings in the company.

Future Outlook

The newly granted restricted stock units vest in four equal annual installments beginning on February 28, 2025, incentivizing continued performance.

Industry Context

Executive stock transactions are common in publicly traded companies and are closely watched by investors as indicators of management's confidence in the company's prospects. These transactions are a normal part of executive compensation.

Comparison to Industry Standards

• Executive compensation packages, including restricted stock units, are standard practice among publicly traded companies in the healthcare sector.
• The vesting schedules and terms of these units are generally comparable to those offered by peer companies to align executive incentives with shareholder value creation.
• Companies like Guardant Health, Inc. and Illumina, Inc. also utilize restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a small number of shares relative to the total outstanding.
• The vesting of restricted stock units incentivizes the executive to continue driving company performance, which benefits all stakeholders.

Key Dates